Viewing nowCombinationTwin One Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.

MFDS item code 201605734 · Approved 2016.09.30 · Insurance code 658203420
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or telmisartan alone. This helps reduce the risk of cardiovascular complications due to hypertension and contributes to maintaining healthy blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, a direct switch to this medicine may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Pediatric patients 18 years of age or younger: Use of this medicine is not recommended because its safety and efficacy have not been established.
This medication may pose serious risks to the fetus, especially during the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. Patients with allergies to any of the ingredients in this medication or severe liver impairment, severe hypotension, or severe heart-related diseases should not take this medication. Patients with poor liver function, gastrointestinal diseases, kidney problems, the elderly, etc., should take special care when using this medication. This medication may cause side effects such as dizziness, edema, and lowering of blood pressure, so consult a doctor if symptoms are severe. Since this is a medication that lowers blood pressure, if symptoms of hypotension occur, lie down immediately and rest, and receive IV treatment at a hospital if necessary. This medication can interact with other drugs, so if you are taking any other medications, be sure to inform your doctor or pharmacist. Women who are breastfeeding should also avoid taking this medication, and if pregnancy is planned or occurring, should switch to another safe treatment method. This medication is not recommended for children or adolescents under the age of 18 as safety and efficacy have not been sufficiently established. Elderly patients may respond more sensitively to this medication, so caution is needed when taking it, and dosage adjustment may be necessary. In case of overdose, severe hypotension, dizziness, and heart problems may occur, so visit a medical institution immediately for appropriate treatment. This medication should be kept out of the reach of children and stored in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that blocks light, at room temperature between 1 to 30 degrees Celsius. Storing in this manner helps maintain the medication's effectiveness and prevents deterioration.
This is a white and light gray double-layered oval tablet with convex surfaces on both sides.
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
(Co., Ltd.) CMG Pharmaceutical
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.